ArticleHuman vaccines & immunotherapeutics2012

Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.

Pawel Grzesiowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.